Ultradian variations of chromogranin A in humans
- PMID: 1681748
- DOI: 10.1152/ajpregu.1991.261.4.R939
Ultradian variations of chromogranin A in humans
Abstract
Chromogranin A (CgA) is an acidic soluble protein exocytotically released from virtually all neuroendocrine secretory vesicles. Here we examined spontaneous variations in CgA and catecholamine concentrations in humans. In normal subjects, basal CgA showed no day-to-day, week-to-week, or diurnal variability. Plasma CgA had significant ultradian variation in normotensives and hypertensives, and in bilaterally adrenalectomized subjects. Gender, but not age or blood pressure, influenced CgA variations, males having fewer (P less than 0.05) peaks per 8 h. Plasma catecholamines had significant ultradian variations in both controls and bilaterally adrenalectomized subjects. Within individuals, neither basal nor peak plasma CgA correlated with catecholamines, nor was there concordance between plasma CgA and catecholamine peaks. Somatostatin, a widespread inhibitor of nonsympathoadrenal neuroendocrine secretion, diminished both the frequency and amplitude of plasma CgA peaks. Thus spontaneous variations in basal CgA are not directly linked to alterations in sympathoadrenal catecholamine secretion. Furthermore, neuroendocrine secretion at sites other than the sympathoadrenal system contributes to spontaneous variations in CgA concentration.
Similar articles
-
Chromogranin 'A' in normal subjects, essential hypertensives and adrenalectomized patients.Clin Endocrinol (Oxf). 2002 Jul;57(1):41-50. doi: 10.1046/j.1365-2265.2002.01557.x. Clin Endocrinol (Oxf). 2002. PMID: 12100068
-
Neuroendocrine sources of chromogranin-A in normal man: clues from selective stimulation of endocrine glands.J Clin Endocrinol Metab. 1990 Aug;71(2):360-9. doi: 10.1210/jcem-71-2-360. J Clin Endocrinol Metab. 1990. PMID: 2116438
-
Suppression of chromogranin-A release from neuroendocrine sources in man: pharmacological studies.J Clin Endocrinol Metab. 1991 Mar;72(3):616-22. doi: 10.1210/jcem-72-3-616. J Clin Endocrinol Metab. 1991. PMID: 1671783
-
Circulating chromogranin A and catecholamines in human fetuses at uneventful birth.Pediatr Res. 1995 Jan;37(1):101-5. doi: 10.1203/00006450-199501000-00019. Pediatr Res. 1995. PMID: 7700724 Clinical Trial.
-
Chromogranin A: its clinical value as marker of neuroendocrine tumours.Eur J Clin Invest. 1998 Jun;28(6):431-40. doi: 10.1046/j.1365-2362.1998.00305.x. Eur J Clin Invest. 1998. PMID: 9693933 Review.
Cited by
-
Circadian variations in salivary chromogranin a concentrations during a 24-hour period in dogs.J Vet Sci. 2008 Dec;9(4):421-3. doi: 10.4142/jvs.2008.9.4.421. J Vet Sci. 2008. PMID: 19052500 Free PMC article.
-
Catestatin and vasostatin concentrations in healthy dogs.Acta Vet Scand. 2017 Jan 3;59(1):1. doi: 10.1186/s13028-016-0274-8. Acta Vet Scand. 2017. PMID: 28049540 Free PMC article.
-
Chromogranin A plasma levels predict mortality in COVID-19.PLoS One. 2022 Apr 25;17(4):e0267235. doi: 10.1371/journal.pone.0267235. eCollection 2022. PLoS One. 2022. PMID: 35468164 Free PMC article.
-
A meal test improves the specificity of chromogranin A as a marker of neuroendocrine neoplasia.Tumour Biol. 2010 Oct;31(5):373-80. doi: 10.1007/s13277-010-0045-5. Epub 2010 May 18. Tumour Biol. 2010. PMID: 20480408 Clinical Trial.
-
Decreased plasma Chromogranin A361-372 (Catestatin) but not Chromogranin A17-38 (Vasostatin) in female dogs with bacterial uterine infection (pyometra).BMC Vet Res. 2015 Jan 31;11:14. doi: 10.1186/s12917-015-0328-6. BMC Vet Res. 2015. PMID: 25636335 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous